| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |